Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$22.9M
Filings
121
Firms Hired
6
Active Period
2018–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Chinese Military and Surveillance Company Sanctions Act of 2023
2024 · first_quarter · Firm: SK HYNIX AMERICA, INC.
Overview of company; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. supply chain policy; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to international trade; Monitor appropriations and finance issues
Client expense: $970,000 · Firm income: —
Matched citations: H.R. 760
National Defense Authorization Act for Fiscal Year 2024
2023 · fourth_quarter · Firm: SK HYNIX AMERICA, INC.
Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; H.R. 2670, the National Defense Authorization Act (issues relating to the screening of international investments); H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; S. 2226, the National Defense Authorization Act for FY 2024 (issues relating to the screening of international investments); Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; Issues relating to international trade; Issues related to an international business transaction; Monitor appropriations and finance issues
Client expense: $990,000 · Firm income: —
Matched citations: H.R. 2670
Chinese Military and Surveillance Company Sanctions Act of 2023
2023 · fourth_quarter · Firm: SK HYNIX AMERICA, INC.
Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; H.R. 2670, the National Defense Authorization Act (issues relating to the screening of international investments); H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; S. 2226, the National Defense Authorization Act for FY 2024 (issues relating to the screening of international investments); Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; Issues relating to international trade; Issues related to an international business transaction; Monitor appropriations and finance issues
Client expense: $990,000 · Firm income: —
Matched citations: H.R. 760
National Defense Authorization Act for Fiscal Year 2024
2023 · fourth_quarter · Firm: SK HYNIX AMERICA, INC.
Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; H.R. 2670, the National Defense Authorization Act (issues relating to the screening of international investments); H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; S. 2226, the National Defense Authorization Act for FY 2024 (issues relating to the screening of international investments); Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; Issues relating to international trade; Issues related to an international business transaction; Monitor appropriations and finance issues
Client expense: $990,000 · Firm income: —
Matched citations: S. 2226
National Defense Authorization Act for Fiscal Year 2024
2023 · third_quarter · Firm: SK HYNIX AMERICA, INC.
General trade and investment issues; Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; H.R. 2670, the National Defense Authorization Act (issues relating to the screening of international investments); H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; S. 2226, the National Defense Authorization Act for FY 2024 (issues relating to the screening of international investments)
Client expense: $1,070,000 · Firm income: —
Matched citations: H.R. 2670
Chinese Military and Surveillance Company Sanctions Act of 2023
2023 · third_quarter · Firm: SK HYNIX AMERICA, INC.
General trade and investment issues; Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; H.R. 2670, the National Defense Authorization Act (issues relating to the screening of international investments); H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; S. 2226, the National Defense Authorization Act for FY 2024 (issues relating to the screening of international investments)
Client expense: $1,070,000 · Firm income: —
Matched citations: H.R. 760
National Defense Authorization Act for Fiscal Year 2024
2023 · third_quarter · Firm: SK HYNIX AMERICA, INC.
General trade and investment issues; Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to U.S. export control policy, licensing policy, Validated End-user license status, and related procedures; H.R. 2670, the National Defense Authorization Act (issues relating to the screening of international investments); H.R. 760, the Chinese Military and Surveillance Company Sanctions Act; Issues relating to, and strategic implications of, U.S. export control policy and supply chain policy; S. 2226, the National Defense Authorization Act for FY 2024 (issues relating to the screening of international investments)
Client expense: $1,070,000 · Firm income: —
Matched citations: S. 2226
Educate policymakers on electric vehicles and monitor legislative proposals. Monitor the implementation of PL 117-58, the Infrastructure Investment and Jobs Act, and PL 117-169, the Inflation Reduction Act, particularly rulemakings regarding electric vehicle batteries. Monitor H.R.3938, the Build It in America Act.
Client expense: — · Firm income: $140,000
Matched citations: H.R.3938
Educate policymakers on electric vehicles and monitor legislative proposals. Monitor the implementation of PL 117-58, the Infrastructure Investment and Jobs Act, and PL 117-169, the Inflation Reduction Act, particularly rulemakings regarding electric vehicle batteries. Monitor H.R.3746, the Fiscal Responsibility Act, and H.R.3938, the Build it in America Act.
Client expense: — · Firm income: $140,000
Matched citations: H.R.3746
Educate policymakers on electric vehicles and monitor legislative proposals. Monitor the implementation of PL 117-58, the Infrastructure Investment and Jobs Act, and PL 117-169, the Inflation Reduction Act, particularly rulemakings regarding electric vehicle batteries. Monitor H.R.3746, the Fiscal Responsibility Act, and H.R.3938, the Build it in America Act.
Client expense: — · Firm income: $140,000
Matched citations: H.R.3938
Monitor proposals and issues related to biopharmaceuticals such as S.3799, PREVENT Pandemics Act, and H.R. 834, PREPARE Act.
Client expense: — · Firm income: $130,000
Matched citations: H.R. 834
Monitor proposals and issues related to biopharmaceuticals such as S.3799, PREVENT Pandemics Act, and H.R. 834, PREPARE Act.
Client expense: — · Firm income: $130,000
Matched citations: S.3799
CHIPS Act of 2022 (H.R. 4346)
Client expense: — · Firm income: —
Matched citations: H.R. 4346
CHIPS Act of 2022 (H.R. 4346)
Client expense: — · Firm income: —
Matched citations: H.R. 4346
United States Innovation and Competition Act of 2021
2021 · third_quarter · Firm: INVARIANT LLC
Monitor proposals on semiconductors, including S.1260, U.S. Innovation and Competition Act.
Client expense: — · Firm income: $120,000
Matched citations: S.1260
Source: Senate LDA